Dr Anthony Cheung graduated from his BSc and MRes degrees at the University of Glasgow in Biomedical Sciences. He has then held a variety of roles at King's College London in the past decade. He joined Professor Philip Blower and Professor Paul Banga at the Division of Imaging Sciences as a Research Assistant to develop molecular imaging agents for the diagnosis of thyroid cancer.
Under the supervision of Professor Tony Ng, his PhD project at King’s focused on formulating liposomes for in vivo delivery of FLIM-based sensor to study intratumoral heterogeneity of EGFR activity and conducted a high-content high-throughput FLIM screen to interrogate protein-protein interactions.
He was awarded the PhD in 2013 and joined Professor Andrew Tutt and Dr Sophia Karagiannis as a Research Associate supported by Breast Cancer Now. He has authored 13 peer-reviewed publications to-date and co-supervised 11 PhD or MSc students.
Anthony’s research interests are concentrated on establishing novel therapeutic targets in triple-negative breast cancer and interrogating the tumour-infiltrating lymphocyte compartment, especially how immunotherapies or antibody-drug conjugates (ADCs) may play a role in breast cancer treatment.